KBC Group NV Decreases Stock Holdings in The Clorox Company $CLX

Posted by George Bondi on Jul 25th, 2026

KBC Group NV reduced its position in The Clorox Company (NYSE:CLX – Free Report) by 29.4% during the first quarter, Holdings Channel reports. The institutional investor owned 33,418 shares of the company’s stock after selling 13,936 shares during the quarter. KBC Group NV’s holdings in Clorox were worth $3,463,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Caitlin John LLC lifted its position in Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after acquiring an additional 253 shares during the last quarter. Darwin Wealth Management LLC acquired a new position in shares of Clorox during the second quarter worth $29,000. Vision Financial Markets LLC increased its position in shares of Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares in the last quarter. Root Financial Partners LLC lifted its holdings in shares of Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after purchasing an additional 145 shares during the last quarter. Finally, SHP Wealth Management purchased a new stake in shares of Clorox during the 4th quarter valued at $35,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on CLX shares. UBS Group boosted their target price on Clorox from $96.00 to $100.00 and gave the stock a “neutral” rating in a research note on Thursday, July 16th. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Morgan Stanley dropped their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. JPMorgan Chase & Co. cut their price objective on shares of Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a report on Thursday, July 16th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and an average target price of $102.80.

Get Our Latest Stock Report on CLX

Clorox Trading Up 1.9%

Shares of Clorox stock opened at $95.61 on Friday. The stock has a market cap of $11.56 billion, a PE ratio of 15.52 and a beta of 0.54. The firm has a fifty day moving average price of $95.10 and a 200 day moving average price of $103.83. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $131.86.

Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the business earned $1.45 earnings per share. The company’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts predict that The Clorox Company will post 5.52 earnings per share for the current year.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.63% of the stock is currently owned by company insiders.

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.